DMK Pharmaceuticals Corporation Common Stock
DMK was delisted on the 6th of February, 2024.
3 hedge funds and large institutions have $4 invested in DMK Pharmaceuticals Corporation Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 27 closing their positions.
90% less funds holding
Funds holding: 29 → 3 (-26)
96% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 27
100% less capital invested
Capital invested by funds: $351K → $4 (-$351K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OPTFSNA
Old Point Trust & Financial Services N A
Newport News,
Virginia
|
+$8 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$74.4K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$72.5K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
-$49.8K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$45.6K |
| 5 |
BlackRock
New York
|
-$27.1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
S
26
SignatureFD
Atlanta,
Georgia
| – | -$8 | -12 | Closed |
|
|
CPG
27
Cornerstone Planning Group
Fairfield,
New Jersey
| – | -$5 | -7 | Closed |
|
|
CIA
28
Cape Investment Advisory
Mcdonough,
Georgia
| – | -$1 | -1 | Closed |
|
29
Fidelity Investments
Boston,
Massachusetts
| – | -$1 | -1 | Closed |
|
DMK Hedge Fund Activity: Q1 2024 in Review
3 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q1 2024, worth a combined $4 — down 100% from $351K a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of DMK and 1 opened new positions — a net loss of 26 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Old Point Trust & Financial Services N A, opening a new position worth an estimated $8. The largest seller was JP Morgan Chase, exiting entirely with an estimated $74.4K sold.
- 3 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q1 2024, down from 29 in Q4 2023.
- Funds reported $4 of DMK Pharmaceuticals Corporation Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
- 1 fund opened new DMK Pharmaceuticals Corporation Common Stock positions in Q1 2024 and 27 closed out, a net change of -26 holders.
- The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q1 2024 was Old Point Trust & Financial Services N A, an estimated $8 added.
- The largest DMK Pharmaceuticals Corporation Common Stock seller in Q1 2024 was JP Morgan Chase, an estimated $74.4K sold.
Based on aggregated 13F filings for Q1 2024.